相关实验视频

Updated: Jun 27, 2025

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

在治疗缺血性中风的先进的纳米药物输送系统

Jiajie Zhang¹, Zhong Chen¹, Qi Chen²

¹Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Molecules (Basel, Switzerland)

|April 27, 2024

概括

纳米药物输送系统为缺血性中风提供了有希望的治疗方法,解决了诸如血脑屏障和再输液损伤等挑战. 这些先进的系统显示出改善中风患者治疗结果的潜力.

科学领域:

神经科学是一个神经科学.
生物医学工程生物医学工程
药理学药理学是指药理学的学科.

背景情况:

脑卒中是全球主要的死亡原因,死亡率和残疾率很高.
缺血性中风和随后的再输液损伤涉及复杂的病理过程.
传统治疗因血脑屏障而面临局限性,阻碍了药物的疗效.

研究的目的:

审查中风再注射损伤的病理机制.
总结纳米药物输送系统 (NDDS) 对缺血性中风的治疗进展.
提供关于NDDS在治疗脑缺血症方面的当前研究进展的见解.

主要方法:

文献综述侧重于中风病理生理学和纳米药物输送系统.
对针对大脑缺血性疾病的功能化NDDS的研究分析.
讨论NDDS的特性,如生物相容性,效率和特异性.

主要成果:

纳米药物输送系统显示出良好的生物相容性和高准效率.
功能化的NDDS显示出在治疗中风时克服血脑屏障的巨大潜力.
NDDS提供了一个有前途的途径来管理复杂的反伤害级联.

结论:

纳米药物输送系统代表了治疗缺血性中风的重大进步.
对NDDS的进一步研究对于开发更有效的中风疗法至关重要.
NDDS有望通过增强跨血脑屏障的药物输送来改善患者的治疗结果.

关键词:

血脑屏障血脑屏障血脑屏障血脑屏障缺血性中风中风纳米药物输送系统的系统.纳米颗粒是一种纳米粒子.

更多相关视频

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions

Published on: January 18, 2016

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

相关概念视频

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...